Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray + oliceridine MAC versus laryngeal mask general anesthesia in elderly EE-DCR
ChiCTR2600134587Phase 4Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and oliceridine in dacryostenosis and dacryocystitis (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Coefficient of Variation of Mean Arterial Pressure. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineoliceridine
03
Conditions
dacryostenosisdacryocystitis
Beyond the preview
Go deeper on ChiCTR2600134587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134587.